Cargando…
Non-motor symptoms of Parkinson’s disease: the patient’s perspective
Parkinson’s disease (PD) can be manifested in many different ways. Although motor dysfunction represents the best characterised of the symptoms, the non-motor symptoms (NMS) of the condition can be equally disabling for people. These have been highlighted as being an issue of particular importance b...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611030/ https://www.ncbi.nlm.nih.gov/pubmed/23224635 http://dx.doi.org/10.1007/s00702-012-0928-2 |
_version_ | 1782264526859665408 |
---|---|
author | Breen, Kieran C. Drutyte, Gerda |
author_facet | Breen, Kieran C. Drutyte, Gerda |
author_sort | Breen, Kieran C. |
collection | PubMed |
description | Parkinson’s disease (PD) can be manifested in many different ways. Although motor dysfunction represents the best characterised of the symptoms, the non-motor symptoms (NMS) of the condition can be equally disabling for people. These have been highlighted as being an issue of particular importance by people with PD. A comprehensive postal survey of members of the charity Parkinson’s UK took place in 2008. This resulted in returns from 10,101 people with PD. The self-completed Non-Motor Questionnaire (NMSQuest) and quality of life scale (PDQ-8) were contained within the survey. The results showed that the percentage of people with PD experiencing NMS increased with the duration of the disease. However, people who had the younger onset form of the condition reported a greater impact of NMS, particularly in the areas of memory, depression and sleep function. There is an inverse correlation between NMS and (PDQ-8 scale). A significant number of people with PD reported that they experienced problems with olfaction, taste, nocturia and constipation prior to diagnosis and these may help to serve as a future biomarker for the condition. Although our understanding of PD-associated NMS has increased considerably in the recent past, there is still a general lack of awareness of the importance of NMS for people with PD. Further research is required to identify the best treatments that should be employed to address them. |
format | Online Article Text |
id | pubmed-3611030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-36110302013-04-01 Non-motor symptoms of Parkinson’s disease: the patient’s perspective Breen, Kieran C. Drutyte, Gerda J Neural Transm (Vienna) Neurology and Preclinical Neurological Studies - Original Article Parkinson’s disease (PD) can be manifested in many different ways. Although motor dysfunction represents the best characterised of the symptoms, the non-motor symptoms (NMS) of the condition can be equally disabling for people. These have been highlighted as being an issue of particular importance by people with PD. A comprehensive postal survey of members of the charity Parkinson’s UK took place in 2008. This resulted in returns from 10,101 people with PD. The self-completed Non-Motor Questionnaire (NMSQuest) and quality of life scale (PDQ-8) were contained within the survey. The results showed that the percentage of people with PD experiencing NMS increased with the duration of the disease. However, people who had the younger onset form of the condition reported a greater impact of NMS, particularly in the areas of memory, depression and sleep function. There is an inverse correlation between NMS and (PDQ-8 scale). A significant number of people with PD reported that they experienced problems with olfaction, taste, nocturia and constipation prior to diagnosis and these may help to serve as a future biomarker for the condition. Although our understanding of PD-associated NMS has increased considerably in the recent past, there is still a general lack of awareness of the importance of NMS for people with PD. Further research is required to identify the best treatments that should be employed to address them. Springer Vienna 2012-12-07 2013 /pmc/articles/PMC3611030/ /pubmed/23224635 http://dx.doi.org/10.1007/s00702-012-0928-2 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Neurology and Preclinical Neurological Studies - Original Article Breen, Kieran C. Drutyte, Gerda Non-motor symptoms of Parkinson’s disease: the patient’s perspective |
title | Non-motor symptoms of Parkinson’s disease: the patient’s perspective |
title_full | Non-motor symptoms of Parkinson’s disease: the patient’s perspective |
title_fullStr | Non-motor symptoms of Parkinson’s disease: the patient’s perspective |
title_full_unstemmed | Non-motor symptoms of Parkinson’s disease: the patient’s perspective |
title_short | Non-motor symptoms of Parkinson’s disease: the patient’s perspective |
title_sort | non-motor symptoms of parkinson’s disease: the patient’s perspective |
topic | Neurology and Preclinical Neurological Studies - Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611030/ https://www.ncbi.nlm.nih.gov/pubmed/23224635 http://dx.doi.org/10.1007/s00702-012-0928-2 |
work_keys_str_mv | AT breenkieranc nonmotorsymptomsofparkinsonsdiseasethepatientsperspective AT drutytegerda nonmotorsymptomsofparkinsonsdiseasethepatientsperspective |